Differences in clinical trial patient attributes and outcomes according to enrollment setting.
J. Clin. Oncol., Jan;28(2):215-21 (2010)
Does oral antiandrogen use before leuteinizing hormone-releasing hormone therapy in patients with metastatic prostate cancer prevent clinical consequences of a testosterone flare?
Urology., Mar;75(3):642-7 (2010)
End-of-life care for older cancer patients in the Veterans Health Administration versus the private sector.
Cancer., Aug;116(15):3732-9 (2010)
Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration.
Cancer., Jul;118(13):3345-55 (2012)
Location of cancer surgery for older veterans with cancer.
Health Serv Res., Apr;47(2):783-93 (2012)
Utility of administrative claims data for the study of brain metastases: a validation study.
J. Neurooncol., Dec;95(3):427-31 (2009)
Understanding variation in primary prostate cancer treatment within the Veterans Health Administration.
Urology., Mar;79(3):537-45 (2012)
Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare.
J. Clin. Oncol., Apr;30(10):1072-9 (2012)
Do Socially Deprived Urban Areas Have Lesser Supplies of Cancer Care Services?
J. Clin. Oncol., Aug (2012)
Do socially deprived urban areas have lesser supplies of cancer care services?
J. Clin. Oncol., Sep;30(26):3250-7 (2012)
Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.
J. Natl. Cancer Inst., Jul;97(14):1080-3 (2005)
A demographic and prognostic approach to defining the end of life.
J Palliat Med., 8 Suppl 1:S12-21 (2005)
Sensitivity of Medicare Claims Data for Measuring Use of Standard Multiagent Chemotherapy Regimens.
NSAIDs and colorectal cancer risk: do administrative data support a chemopreventive effect?
J Gen Intern Med., Aug;22(8):1166-71 (2007)
Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344).
J. Natl. Cancer Inst., Sep;98(18):1335-8 (2006)